CR
CRDA.LSE Croda International PLC
- Market cap
- GBX 5.01B
- P/E
- 63.6x
- P/B
- 2.34x
- ROE
- 14.5%
- Dividend yield
- 3.03%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is CRDA.LSE undervalued?
Graham numberCRDA.LSE trades 157.0% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Croda International PLC fundamental analysis
No fundamental analysis for Croda International PLC yet.
Croda International PLC stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Croda International PLC
Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers consumer care products across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, crop protection, and seed coating systems and enhancement technologies to improve germination. In addition, the company…
Full company profileCroda International PLC financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Croda International PLC annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.24B | 1.37B | 1.39B | 1.38B | 1.39B | 1.89B | 2.09B | 1.69B | 1.63B | 1.70B | 3.52B |
| Gross Profit | 445M | 517M | 522M | 446M | 550M | 826M | 865M | 730M | 734M | 609M | 1.29B |
| Operating Income | 283M | 323M | 331M | 336M | 308M | 437M | 478M | 248M | 228M | 244M | 552M |
| EBITDA | 336M | 380M | 386M | 386M | 370M | 549M | 925M | 389M | 375M | 381M | 832M |
| Net Income | 197M | 237M | 239M | 224M | 202M | 321M | 649M | 171M | 159M | 62.0M | 315M |
| EPS | 1.50 | 1.83 | 1.85 | 1.72 | 1.55 | 2.29 | 4.65 | 1.22 | 1.13 | 0.44 | 2.25 |
| Balance Sheet | |||||||||||
| Total Assets | 1.50B | 1.65B | 1.91B | 1.89B | 3.03B | 3.29B | 3.61B | 3.58B | 3.51B | 3.41B | 3.53B |
| Total Liabilities | 891M | 819M | 915M | 1.02B | 1.43B | 1.53B | 1.18B | 1.21B | 1.21B | 1.21B | 1.34B |
| Shareholders' Equity | 601M | 822M | 991M | 862M | 1.59B | 1.75B | 2.42B | 2.35B | 2.28B | 2.19B | 2.17B |
| Cash & Short-term Investments | 61.0M | 63.3M | 71.2M | 81.9M | 107M | 113M | 321M | 173M | 167M | 173M | 205M |
| Total Debt | 425M | 445M | 497M | 630M | 907M | 936M | 616M | 710M | 699M | 697M | 783M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 264M | 263M | 262M | 304M | 287M | 348M | 308M | 338M | 319M | 290M | 364M |
| Capital Expenditure | 104M | 156M | 100M | 111M | 121M | 159M | 152M | 189M | 182M | 118M | 167M |
| Free Cash Flow | 160M | 107M | 162M | 193M | 166M | 189M | 156M | 157M | 138M | 172M | 197M |
| Ratios | |||||||||||
| ROE | 32.8% | 28.8% | 24.1% | 26.0% | 12.7% | 18.3% | 26.9% | 7.3% | 6.9% | 2.8% | 14.5% |
| ROA | 13.1% | 14.4% | 12.5% | 11.8% | 6.7% | 9.7% | 18.0% | 4.8% | 4.5% | 1.8% | 8.9% |
| Net Profit Margin | 15.8% | 17.3% | 17.2% | 16.3% | 14.5% | 17.0% | 31.1% | 10.1% | 9.7% | 3.6% | 8.9% |
| Debt to Equity | 0.71x | 0.54x | 0.50x | 0.73x | 0.57x | 0.53x | 0.25x | 0.30x | 0.31x | 0.32x | 0.36x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Croda International PLC dividends
- Dividend yield
- 3.03%
- Forward dividend
- 1.11 GBX
- Payout ratio
- 249.8%
- Ex-dividend date
- Aug 27, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | GBP 155M | 1.11 | 249.8% |
| 2024 | GBP 152M | 1.09 | 96.0% |
| 2023 | GBP 151M | 1.08 | 88.1% |
| 2022 | GBP 144M | 1.03 | 22.2% |
| 2021 | GBP 133M | 0.95 | 41.3% |
| 2020 | GBP 116M | 0.89 | 57.5% |
| 2019 | GBP 267M | 2.05 | 119.2% |
| 2018 | GBP 111M | 0.86 | 46.3% |
| 2017 | GBP 100M | 0.77 | 42.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 41:42 on Apr 29, 2019.
Who owns Croda International PLC
- Insiders 1.23%
- Institutions 61.51%
- Public & others 37.27%
- Shares outstanding 139M
- Free float 128M
Croda International PLC company profile
- Company name
- Croda International PLC
- Ticker
- CRDA.LSE
- ISIN
- GB00BJFFLV09
- Exchange
- London Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 5,954
- Fiscal year end
- December
- Address
- Cowick Hall, Goole, United Kingdom, DN14 9AA
- Phone
- 44 1405 860551
- Website
- croda.com
About Croda International PLC
Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers consumer care products across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, crop protection, and seed coating systems and enhancement technologies to improve germination. In addition, the company offers industrial specialties, including phase change materials; surfactants, such as emulsifiers, dispersants, wetting agents, detergents, and polymerics; and formulated textile and spin finishes. Croda International Plc was incorporated in 1925 and is headquartered in Goole, the United Kingdom.
Croda International PLC management
10- Mr. Stephen Edward Foots CBEGroup Chief Executive & Executive Director · born 1968
- Mr. Stephen Richard OxleyCFO & Executive Director · born 1971
- Mr. David BishopDirector of Investor Relations
- Mr. Thomas Michael Brophy M.D.Group General Counsel, Company Secretary & President Sustainability · born 1974
- Mr. Anthony Damien FitzpatrickPresident of Strategy, Corporate Development & Industrial Specialties
- Ms. Michelle LydonPresident of Human Resources · born 1972
- Ms. Sandra Elaine BreenePresident of Consumer Care
- Mr. Philip RuxtonChief Sustainability Officer
- Mr. Thomas RiemeierPresident of Life Sciences
- Mr. Thiru SelvanPresident of Supply Chain Operations